Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
171 Leser
Artikel bewerten:
(0)

Samarkand Group plc: FY21 Preliminary Unaudited Results

DJ Samarkand Group plc: FY21 Preliminary Unaudited Results

Samarkand Group plc (SMK) 
Samarkand Group plc: FY21 Preliminary Unaudited Results 
29-Jul-2021 / 07:00 GMT/BST 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
29 July 2021 
 
Samarkand Group plc 
("Samarkand", the "Company" or together with its subsidiaries the "Group") 
 
FY21 Preliminary Unaudited Results 
 
Samarkand Group plc, the cross-border eCommerce technology solution provider, is pleased to announce its preliminary 
unaudited results for the year ended 31 March 2021 ("FY21"). 
 
FY21 Financial highlights: 
 - Listed on the Apex segment of the AQSE Growth Market raising GBP17m 
 - Revenue increased significantly by 201% to GBP20.6m (2020: GBP6.8m) 
 - Like for like revenues increased 116% to GBP14.8m (2020: GBP6.8m) excluding the exceptional revenues of GBP5.8m 
   - Nomad Technology revenue increased 317% to GBP6.4m (2020: GBP1.5m) 
   - Brand Ownership revenues increased 66% to GBP3.5m (2020: GBP2.1m) 
   - Distribution revenues increased 51% to GBP4.8m (2020: GBP3.2m) 
 - Gross margin, excluding exceptional revenue, improved from 48% to 62% reflecting a shift to greater technology and 
  direct-to-consumer revenues 
 - EBITDA profit increased to GBP1.1m* (2020: loss GBP0.8m) 
 - Adjusted EBITDA loss improved 50% to GBP0.4** (2020: loss GBP0.8m) 
* after deducting GBP0.5m in listing fees and share based payment charge 
** adjusted EBITDA is EBITDA adjusted to exclude the profit generated from exceptional revenues, listing fees and share 
based payment charge. 
FY21 Operational highlights: 
 - Orders processed for consumers in China increased 107% to 122k (2020: 59k) 
 - Number of product lines processed on the Nomad platform in 2021 was 2,111 (2020: 381) 
 - Significant investment in the Group's proprietary technology platform, Nomad continued with GBP0.6m (2020: GBP0.4m) in 
  capitalised development costs 
 - Nomad Checkout enterprise launched in November 2020 with c. GBP1m GMV processed on the platform on behalf of UK 
  brands and retailers 
Post period end highlights: 
 - GBP3.1m net investment received from our strategic partner SF Express 
 - Acquired Zita West Products Limited and majority interest in Babawest Ltd 
 - Established Samarkand Global (Japan) KK based in Tokyo 
 - Nomad Checkout beta launched on 4 SME brands 
David Hampstead, Chief Executive Officer of Samarkand Group, commented: "It has been an exceptional year for Samarkand 
Group plc and I am extremely proud to be presenting the Group's maiden set of results as a listed Company. The ability 
with which the Company has progressed during the period in the face of the challenges posed by the pandemic is 
testament to the strength of our team and the value of our offering. I would like to take this opportunity to thank all 
our staff for their continued hard work. 
 
The funds raised from our IPO provides Samarkand with the necessary capital to move to the next stage of our expansion 
and continued execution of our growth strategy. The use of such funds to acquire Zita West Products and a majority 
interest in Babawest Ltd underlines the ambition of the Group to move quickly in its progression. We continue to assess 
further opportunities for acquisitive growth. 
Chinese eCommerce is only set to grow in significance moving forwards and our offering provides the optimal route for 
Western brands to penetrate the notoriously difficult Chinese market. The future of the Company is extremely bright and 
I am excited to continue delivering on our stated strategy in the coming months." 
For more information, please contact: 
 
Samarkand Group plc                     Via Alma PR 
David Hampstead, Chief Executive Officer 
                              http://samarkand.global/ 
Eva Hang, Chief Financial Officer 
 
VSA Capital - AQSE Corporate Adviser and Broker       +44(0)20 3005 5000 
Andrew Raca, James Deathe, Pascal Wiese (Corporate Finance) 
                              IPO@vsacapital.com 
Andrew Monk (Corporate Broking) 
 
Alma PR                           +44(0)20 3405 0213 
Josh Royston 
Robyn Fisher                        samarkand@almapr.co.uk 
Joe Pederzolli 

Notes to Editors

Samarkand is a cross-border eCommerce technology and retail group focusing on connecting Western Brands with China, the world's largest eCommerce market. The Group has developed a proprietary software platform, the Nomad platform, which is integrated across all necessary touch-points required for eCommerce in China including eCommerce platforms, payments, logistics, social media and customs. The Nomad platform is the foundation on which the Group's Nomad technology and service solutions are built. The core products include Nomad Checkout, Nomad Storefront, Nomad Commerce and Nomad Distribution.

The Company's current customer base comprises leading European brands such as 111SKIN, Shay & Blue, Omorovicza, ICONIC London, Philip Kingsley, Temple Spa and Planet Organic. Samarkand has also successfully grown its own brand, Probio7, acquired in December 2017 and recently announced the acquisition of Zita West Products and Babawest.

Founded in 2016, Samarkand is headquartered in London, UK with offices in Shanghai and Tokyo employing over 140 staff.

For further information please visit https://www.samarkand.global/

CHAIRPERSON'S STATEMENT

Introduction

Despite the challenging year we have all faced the Group continues to build on the strong foundations put in place since incorporation in 2016. I am delighted to have joined such a fast-growing company at such an exciting time and I am particularly pleased to be releasing our maiden full year results as a publicly listed company, following our successful oversubscribed IPO and listing onto the Apex segment of the Aquis Growth Market in March 2021.

The results we are reporting today show the significant progress that has been made over the past year. Our teams have remained focused on providing our customers with a more direct-to-consumer route to the world's largest eCommerce market. The mission of the Company, to connect consumers of the eCommerce market in China with international merchants, comes at a time when the need to reach new markets and new consumer groups has never been greater for businesses of all sizes. The pandemic has made eCommerce even more relevant than ever before, characterised by digital trade and technology and we believe Samarkand is at the frontier of this growing market.

Financial Results

The Group delivered significant revenue growth in FY21 of 201% to GBP20.6m (FY20: GBP6.8m) with like for like revenues increasing 116% to GBP14.8m (FY20: GBP6.8m) excluding exceptional revenues of GBP5.8m. As a result of the proceeds raised at the IPO, the Group has moved from a net debt to net cash position. At the year end, the Group's net cash position was GBP11.6m (2020: net debt GBP5.9m), which provides the ideal platform to execute plans and deliver sustainable value.

People

None of this success would be possible without the passion and diligence shown by our people, who have risen to every challenge posed by the pandemic. These results are a reflection of that endeavour and on behalf of the Board, I offer them my sincere thanks.

Board and governance

At the time of the IPO, we established the Board and governance structures suitable for a fast-growing listed company. The newly formed Board, supported by the Nomination & Remuneration, Sustainability and Audit Committees, bring a breadth of experience in eCommerce, public markets, finance, and governance. We have established a solid working relationship, remaining well connected and communicative despite the restraints of the pandemic. It is a pleasure to work with a group of such knowledgeable and experienced professionals and I am grateful for the contributions that have been made to date.

Summary and Outlook

We operate in one of the fastest changing markets where new trends and technologies can, and do, change the market rapidly. This is what makes this such an exciting industry to operate in but also brings with it a unique set of challenges. The ability to adapt and react quickly to the opportunities this environment brings will be key to our success and we are investing heavily in the technology that will best position us to succeed as this market continues to evolve.

We are making good progress towards our goal of acquiring additional consumer brands and making strategic acquisitions which is evidenced by our recent acquisition of Zita West Products and Baba West Ltd. The focus for the year ahead is to further develop the Nomad platform's functionality and services, as well as expand the Group's business development activities in Europe, Northeast Asia, and North America.

The Group has implemented a "buy in the West, build in the East" strategy in relation to its acquisition of own brands. We plan to continue to extend marketing of our own brands over the coming months. This strategy is focused on the identification of Western brands with growth potential, their acquisition, subsequent redevelopment and launch into the Group's sales channels in China and elsewhere.

The market appetite for our technology is being well received by our customers and we believe that the long term opportunity remains significant. We are continuing to build strong momentum with our customers and our own brands and look positively to the year ahead.

Tanith Dodge

Chairperson

CEO REVIEW

(MORE TO FOLLOW) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

DJ Samarkand Group plc: FY21 Preliminary Unaudited -2-

Despite the many challenges over the last year, it has been a year of phenomenal growth and major milestones achieved by the Group. The stand-out event was our over-subscribed IPO and listing onto the Apex segment of the Aquis Growth Market. Our listing was only possible due to the solid foundations we had built since incorporation and the successful execution of our strategy to make the world's largest but most complex eCommerce market more accessible through our technology and expertise.

Our teams in the UK and China responded and adapted remarkably well to perhaps the most disruptive event in our generation. Our UK distribution centre remained opened throughout the pandemic whilst maintaining the highest levels of safety for the operational teams working there. Our priority going forward is to continue providing a safe working environment and ensuring our teams remain safe, supported and motivated.

Our IPO & Strategic Investment

In March 2021 we successfully completed our IPO and admission on to the Aquis Growth Market in London in what was the first time a growth prospectus had been used in Europe. The IPO was supported by both institutional and retail investors and due to the high demand the amount raised was increased from the initial target of GBP10m to GBP17m. This was quickly followed by a further strategic investment by one of the leading express delivery companies in China, with whom we have been working for several years. Whilst the net proceeds of GBP3.1m will help to accelerate our growth, it is the commitment from such a major partner and the opportunity that represents which is truly significant.

The IPO has enabled many of our colleagues to become shareholders and I am very pleased that over 10.4% of the shares in issue are currently held by employees. The support from our initial investor, Smollan Group, one of the world's leading retail service companies, continues and they converted an GBP1m loan note to equity.

Nomad Technology

The development of our technology continues at pace. We have increased our development and delivery capability to allow us to roll out our solutions faster and further afield. Our solutions are now being deployed by major enterprises in Europe and Asia which represent a huge addressable market. In Europe one of the largest eCommerce companies has deployed our Nomad Checkout solution to their flagship eCommerce site. In Northeast Asia, in line with our strategy to expand into this market, one of the world's largest beauty conglomerates is also deploying our Nomad Checkout solution to power direct-to-consumer sales from South Korea to Chinese consumers. North America is another enormous market opportunity for our technology and the group is already in advance discussions with a major partner for the market. We expect to provide an update on this in due course.

With projects already underway and adoption of our technology by multi-national corporations we are executing our vision of becoming an integral part of the infrastructure that will power eCommerce between China and the rest of the world on the digital silk road. I'm very excited about what comes next and the potential for our solutions to help the millions of smaller merchants that have great potential in the world's largest eCommerce market but currently lack access.

Buy in the West Build in the East

In line with our strategy of acquiring businesses in the West with high growth potential in Asia we completed our first acquisition since the IPO in May. The acquisition of Zita West Products Limited ("ZWPL") and 51% of Baba West Ltd ("BW") is complimentary to the existing health brand owned by the Group, Probio7 and is positioned for significant growth in China through the Group's sales channels and technology. Zita West herself is a world-renowned specialist in fertility, IVF and assisted reproductive therapy (ART). The Zita West clinics have treated thousands of couples and has amongst the highest success rates in the UK. Zita is a widely published author on the subject of fertility and reproductive health and the range of nutritional supplements that have been developed over the last 20 years are specifically designed to support this process. As the global birth rates has dropped, China has become the biggest consumer of ART and in the same month as the acquisition, the Chinese government announced the introduction of a "3 child policy" to reverse the population decline. The acquisition of ZWPL represents a significant opportunity to rapidly grow this brand in the world's largest market.

The performance of our health brand, Probio7, has continued to improve throughout 2020. During the pandemic wholesale to retailer sales dropped significantly due to lockdown closures. The impact of this was offset by the higher margin sales through our own eCommerce channels and the enormous growth the brand experienced in the Chinese market during this period. When we acquired Probio7 in December 2017 it was a brand with a loyal consumer following developed over 20 years and had grown sales to GBP1.2m annually over that time. In FY2021 under our ownership, sales increased to GBP3.5m with over GBP1.7m coming from launching the brand in China.

We will continue to evaluate opportunities and acquisitions that fit within our strategy and are complementary to our portfolio.

Accelerated Investment

The original target for the fund raising of GBP10m was significantly surpassed which has allowed us to invest more aggressively to accelerate our strategy. We have significantly increased investment in our technology and operational teams and have begun the process of expansion into other international markets starting with Japan and continental Europe.

The company now employs over 140 up from 61 in March 2020. All of our employees are working extremely hard to deliver the objectives of the business, innovating and creating solutions to problems that are complex to solve in one of the fastest moving and changing industries. Our technology team which now spans the UK and China has increased from 14 in March 2021 to 23 in July 2021. The team has successfully delivered our unique Nomad Checkout solution across a number of eCommerce sites for one of Europe's largest eCommerce companies, providing a strong validation both of our technology and the addressable market for our solutions.

Markets and the Environment

In 2014, the Chinese government introduced the first policies designed to promote the cross-border eCommerce industry. These included pilot free trade zones, preferential tax policy for goods purchased through this route and dispensations on products in certain categories such as no need for animal testing on skincare and cosmetic products which was previously required for general imports. Since then, this policy has been further strengthened with more free trade zones, even lower tax rates and higher transaction limits. During this time China has become the global leader in eCommerce both in terms of size and scale but also innovation. Social commerce and live-streaming is a phenomenon that started in China and has grown at an incredible rate, from USD4bn in 2017 to a forecasted USD300bn this year. This represents an enormous opportunity but also comes with it's own set of challenges as traffic moves to different platforms and channels at a relentless pace. We have experienced that first-hand with some of the channels we work on moving to Douyin where we didn't have a presence initially. We have now integrated Nomad into this very exciting platform and plan to generate our first sales in the coming months.

An interesting development is the adoption of these livestream technologies and trends appearing in Western markets which presents unique opportunities for the Group as one of the few Western companies with such exposure to what, I believe will become the dominant form of eCommerce for the Post 2000 generation in markets outside of China in the near future.

In the aftermath of the pandemic, there have been some notable developments in the market and industry in which we operate that present future opportunities and challenges. COVID-19 has caused immense disruption to international travel which is one of the ways Western brands have been discovered by Chinese consumers. This disruption has resulted in a rise of domestic Chinese brands replacing the once popular international brands. The almost complete cessation of international travel by Chinese tourists to overseas destinations means that the consumers who do want to purchase international brands have had to do so online which has created opportunities particularly in markets such as Japan and South Korea that have relied on physical retail and tourism. In response we have accelerated our timeline to enter these markets.

Commentary on KPIs

With the launch and rollout of our Nomad Checkout solution, one of the key KPI's we will be focussed over the next 12 months is the adoption and retention of merchants installing and using the solution. The merchant has the option to take an off-the-shelf plugin for eCommerce software platforms such as Shopify or an Enterprise version for companies that require a tailored solution to fit with their own technology and fulfilment processes.

Top line revenue is a key metric however the way we derive that revenue will evolve and change as we execute our plan. We anticipate that as more of our technology is adopted by clients it will become more repeatable and with a higher gross margin than revenue derived from our "buy-and-sell" model and own brand sales.

Outlook statement

(MORE TO FOLLOW) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

DJ Samarkand Group plc: FY21 Preliminary Unaudited -3-

I am extremely proud of what we have achieved over the last few years with a very modest amount of investment. We are truly excited by what the future holds now that we are well resourced. We have a solid foundation operationally, technically, and financially from which we can now build. The adoption of our technology solutions by significant and distinguished companies, combined with the investment from SF Express validates our vision and gives us confidence that the road ahead is a very positive one for the Company. As true pioneers, bridging technical and cultural divides between international merchants and consumers in the world's largest eCommerce market there will inevitably be challenges to overcome but I am confident that the partners and teams we have in place can deliver success.

The pace of change of Chinese eCommerce means we need to be constantly evolving and innovating. We have the benefit of operating in the most dynamic eCommerce market which is now shaping the evolution of eCommerce on a global scale. Chinese eCommerce has been driving trends in other parts of Asia for some time and we are now starting to see that spread to Europe and North America where platforms such as TikTok and trends such as live-stream commerce are starting to gain traction. This is an area where we will be paying close attention given our unique position in both geographies.

Our expansion into Northeast Asia through our newly formed entity and office in Japan represents an enormous and exciting opportunity for us to deploy our solutions and technology to a new market which already has huge demand from Chinese consumers. Japanese and South Korean brands are amongst the most sought-after and the cross-border trade between Chinese consumers and brands from these countries dwarfs that of almost all other markets.

We operate in an innovative, fast-moving eCommerce market, one that is shaping the way consumers shop online and defining what eCommerce will become not just in Asia but in other parts of the world. All aspects of life are accelerating towards digitalisation and the exchange of goods across geographical borders has become part of everyday life for consumers across the globe. It is an exciting time to be building the technology and infrastructure, the pipes and plumbing, that make digital commerce more efficient between international merchants and the world's largest group of consumers in China.

David Hampstead

Chief Executive Officer

FINANCIAL REVIEW

Overview

During the year, the Group demonstrated high growth in revenue and gross profit, as total revenue (including exceptional revenues of GBP5.8m) grew by 201% to GBP20.6m (2020: GBP6.8m) and gross margin improving to 62% (2020: 48%).

Revenues and gross margin

Revenues excluding exceptional revenues are up 116% to GBP14.8m (2020: GBP6.8m), with revenues on our Nomad technology up 317% to GBP6.4m (2020: GBP1.5m), brand ownership revenues up 66% to GBP3.5m (2020: GBP2.1m) and distribution revenues up 51% to GBP4.8m (2020: GBP3.2m).

The significant increases are largely driven by the increase in revenues on our Nomad technology platform, including high levels of social selling, the growth of online sales during the first lockdown, as well as increases in revenue generated from our own brand, Probio7 in China. Due to the temporary closures and reduction in travel, the Group saw a dramatic shift in consumer behaviour towards online shopping, particularly during the months where different parts of the world were in lockdown.

The Group's gross margin (excluding exceptional revenues) increased to 62% (2020: 48%). The improving margins are a result of the Group's continued development of its B2C capabilities and the transition away from its low margin B2B distribution model. In addition, the increasing gross margin performance reflects the Group's focus on technology and services, which typically yields higher margin than distribution sales.

Exceptional Revenues

With teams in both the UK and China the group was ideally positioned to source and supply products necessary for the coronavirus response. As a result, a GBP5.8m government contract from the Department of Health and Social Care (the "Exceptional Revenue") was awarded to the company in April 2020 for the supply of personal protective equipment. This contract was successfully fulfilled.

Operating expenses

Selling and distribution expenses, excluding exceptional revenues have increased to 37% (2020: 22%) of revenue, as a result in the increase in social selling, with transaction fees paid to KOLs as well as an increase in marketing investment in our own brand Probio7. Variable costs (which includes cost of sales, selling and distribution expenses) have remained steady at 76% (2020: 74%) of revenue.

Administrative expenses, excluding exceptional revenues, listing fees, share-based payment expense, decreased to 27% (2020: 38%) of revenue as a result of operational efficiency and the Group's ability to scale its current operations and facilities as revenue grew. With the proceed from the IPO, the Group have begun investing heavy in its people and in additional regulatory, compliance costs as a result of being publicly listed.

Earnings per share

Basic and diluted earnings per share was 0.78 pence per share (2020: (3.93) pence per share).

IPO and net cash/(debt)

The Group listed on the Apex segment of the AQSE Growth Market in March 2021 and raised a total of GBP17m from both institutional investors and qualified investors. The subscription and placing shares represented approximately 29% of the enlarged share capital at the time.

As a result of the proceeds raised at the IPO, the Group has moved from a net debt to net cash position. Alongside the funds raised, the directors' loans, former director loans and loan notes were converted into shares or repaid.

Mar-21   Mar-20 
Cash and cash equivalents    14,606,867 572,586 
Right-of-use lease liabilities (972,994)  (1,216,486) 
Borrowings           (2,082,538) (4,746,478) 
Directors' loans        -      (499,511) 
Net cash / (debt)        11,551,335 (5,889,889) 

At the year end, the Group's net cash position was GBP11.6m (2020: net debt GBP5.9m), which places the Group in a good position to accelerate its growth, bringing forward investments in its technology and increasing its client service, fulfilment and operational capabilities to execute on its plans and deliver on long term value.

Financing costs of GBP0.4m (2020: GBP0.3m) comprised of interest expenses of GBP0.3m (2020: GBP0.3m).

Depreciation and amortisation

The total depreciation and amortisation costs were GBP0.2m and GBP0.3m respectively (2020: GBP0.1m and GBP0.3m). The Group continued to invest in its Nomad Technology platform with a total of GBP0.6m (2020: GBP0.4m) development costs capitalised during the year.

EBITDA

EBITDA increased to GBP1.1m (2020: loss GBP0.8m) after deduction GBP0.5m in listing fees and share based payment charges.

Mar-21  Mar-20 
EBITDA                           1,133,858 (828,971) 
Share-based payment expense                26,914  - 
IPO Listing Fees and restructuring costs          460,174  - 
 
EBITDA before Listing Fees and Share-based payment expense 1,620,946 (828,971) 

The increase in EBITDA is driven by the exceptional revenue contract with the Department of Health and Social Care, which contributed GBP2m in net profit. Adjusted EBITDA has improved from GBP0.8m to GBP0.4m loss.

Mar-21   Mar-20 
EBITDA before Listing Fees and Share-based payment expense 1,620,946  (828,971) 
 
Exceptional Revenues Contract (net profit)         (2,039,621) - 
 
Adjusted EBITDA                      (418,675)  (828,971) 

Going Concern

The financial statements have been prepared on a going concern basis. In adopting this basis, the Directors have carried out a robust assessment of the emerging and principal risks facing the business. As a result of the assessment performed, the Directors consider that the Group has adequate resources to continue its normal course of operations for the foreseeable future.

Consolidated Statement of Comprehensive Income

For the year ended 31 March 2021

Year ended 31 March    Year ended 31 March 
                                   2021           2020 
                                   GBP             GBP 
Revenue                                20,600,541        6,844,100 
Cost of sales                             (8,770,887)        (3,562,548) 
Gross profit                             11,829,654        3,281,552 
Selling and distribution expenses                   (6,189,506)        (1,519,294) 
Administrative expenses                        (4,506,290)        (2,591,229) 
 
Adjusted EBITDA                            (418,675)         (828,971) 
 
Share-based payment expense                      (26,914)         - 
 
IPO Listing Fees and restructuring costs               (460,174)         - 
Exceptional revenue (net profit)                   2,039,621         - 
 
EBITDA                                1,133,858         (828,971) 
Depreciation and amortisation                     (503,354)         (313,069) 
Operating profit/(loss)                        630,504          (1,142,040) 

(MORE TO FOLLOW) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

DJ Samarkand Group plc: FY21 Preliminary Unaudited -4-

Finance income                            115            6,392 
Finance costs                             (401,076)         (296,158) 
Income/(loss) before taxation                     229,543          (1,431,806) 
Taxation                               177,514          44,247 
Income/(loss) after taxation                     407,057          (1,387,559) 
 
Other comprehensive income: 
 
Exchange differences on translation of foreign operations 
                                   (18,517)         (1,331) 
Items that may be reclassified to profit and loss in subsequent 
periods 
                                   (18,517)         (1,331) 
 
Total comprehensive income/(loss) for the year            388,540          (1,388,890) 
 
Income/(loss) attributable to: 
Equity holders of the Company                     405,074          (1,373,059) 
Non-controlling interests                       1,983           (14,500) 
                                   407,057          (1,387,559) 
 
Earnings/(loss) per share (basic and diluted)             0.0078          (0.0393) 
 
Comprehensive income/(loss) attributable to: 
Equity holders of the Company                     386,557          (1,374,390) 
Non-controlling interests                       1,983           (14,500) 
                                   388,540          (1,388,890) 

Consolidated Statement of Financial Position

For the year ended 31 March 2021

31 March 2021  31 March 2020 
                   GBP        GBP 
ASSETS 
Intangible assets          1,462,981    1,083,373 
Property, plant and equipment    151,262     134,550 
Right-of-use assets         840,607     1,072,580 
Non-current assets          2,454,850    2,290,503 
 
Inventories             1,857,239    1,295,193 
Trade receivables          1,013,631    1,056,443 
Corporation tax recoverable     98,893     - 
Other receivables and prepayments  522,022     313,398 
Cash and cash equivalents      14,606,867   572,586 
Current assets            18,098,652   3,237,620 
 
Total assets             20,553,502   5,528,123 
 
EQUITY AND LIABILITIES 
Share capital            516,190     1,767 
Retained earnings          (929,672)    (3,342,203) 
Currency translation reserve     (8,267)     (3,333) 
Capital contribution         -        266,072 
Share premium            17,412,900   - 
Merger relief reserve        (2,063,814)   28,764 
Non-controlling interest       -        (32,168) 
Total equity             14,927,337   (3,081,101) 
 
Right-of-use lease liabilities    720,353     973,512 
Borrowings              1,372,964    1,924,387 
Deferred tax liability        67,576     76,314 
Total non-current liabilities    2,160,893    2,974,213 
 
Trade and other payables       1,981,054    1,661,312 
Accrued liabilities         472,807     204,762 
Deferred revenue           42,563     201,715 
Borrowings              709,574     2,822,091 
Right-of-use lease liabilities    252,641     242,974 
Loans from directors         -        499,511 
Refund liabilities          6,633      2,646 
Total current liabilities      3,465,272    5,635,011 
Total liabilities          5,626,165    8,609,224 
 
Total liabilities and equity     20,553,502   5,528,123 

Consolidated Statement of Changes in Equity

For the year ended 31 March 2021

Currency 
            Share       Merger                      Non-controlling 
                Share   relief   Capital   Translation Retained          Total 
            Capital      reserve                     interests 
                Premium        contribution reserve   earnings          equity 
            GBP    GBP     GBP      GBP      GBP      GBP      GBP        GBP 
Balance at 1 April 2019 1,767  -     28,764   266,072   (2,002)   (1,969,144) (3,716)     (1,678,259) 
 
Loss after taxation   -    -     -      -      -      (1,373,059) (14,500)    (1,387,559) 
 
Other comprehensive   -    -     -      -      (1,331)   -      -        (1,331) 
loss 
 
Total comprehensive   -    -     -      -      (1,331)   (1,373,059) (14,500)    (1,388,890) 
loss for the year 
 
Acquisition of minority -    -     -      -      -      -      (19,970)    (19,970) 
interests 
 
Minority interest 
arising on new     -    -     -      -      -      -      6,018      6,018 
subsidiary 
 
Transactions with    -    -     -      -      -      -      (13,952)    (13,952) 
owners 
 
Balance at 31 March   1,767  -     28,764   266,072   (3,333)   (3,342,203) (32,168)    (3,081,101) 
2020 
 
Profit after taxation  -    -     -      -      -      405,074   1,983      407,057 
 
Other comprehensive   -    -     -      -      (18,517)  -      -        (18,517) 
loss 
 
Total comprehensive 
income/(loss) for the  -    -     -      -      (18,517)  405,074   1,983      388,540 
year 
 
Disposal of minority  -    -     -      -      -      (12,891)  30,185     17,294 
interests 
 
Transactions with    -    -     -      -      -      (12,891)  30,185     17,294 
owners 
 
Share capital reduction 351,633 -     (2,092,578) (266,072)  13,583   1,993,434  -        - 
 
Shares issued on 
listing net of         15,852,283 -      -      -      -      -        16,000,087 
transaction fees    147,804 
 
 
Shares issued on    14,986 1,560,617 -      -      -      -      -        1,575,603 
conversion of loans 
 
Share based payments  -    -     -      -      -      26,914   -        26,914 
            514,423 17,412,900 (2,092,578) (266,072)  13,583   2,020,348  -        17,602,604 
 
Balance at 31 March   516,190 17,412,900 (2,063,814) -      (8,267)   (929,672)  -        14,927,337 
2021 

Consolidated Statement of Cash Flows

For the year ended 31 March 2021

31 March 2021  31 March 2020 
                                           GBP        GBP 
Cash flows from operating activities 
Income/(loss) after taxation                             407,057     (1,387,559) 
Cash flow from operations reconciliation: 
Depreciation and amortisation                            503,354     313,069 
Interest expense                                   314,027     270,927 
Finance income                                    (115)      (4) 
Income tax credit                                  (177,514)    (44,247) 
Share based payment                                 26,914     - 
Working capital adjustments: 
(Increase) in inventories                              (562,046)    (493,588) 
(Increase) in trade and other receivables                      (209,168)    (291,544) 
Increase in trade and other payables                         482,589     1,038,256 
Cash generated from/(used) in operating activities                  785,098     (594,690) 
Taxes received                                    69,883     35,509 
Net cash generated from/(used in) operating activities                854,981     (559,181) 
 
Cash flows from investing activities 
Purchase of property, plant and equipment                      (71,238)    (123,913) 
Payment of intangible assets                             (586,226)    (467,088) 
Acquisition of subsidiary, net of cash acquired                   (9,125)     - 
Disposal of subsidiary, net of cash sold                       17,294     - 
Finance income                                    115       4 
Net cash used in investing activities                        (649,180)    (590,997) 
 
Cash flows from financing activities 
Proceeds from issue of shares, net of fees                      16,000,087   - 
Interest paid                                    -        (73,920) 
Repayment of right-of-use lease liabilities                     (283,424)    (159,512) 

(MORE TO FOLLOW) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

DJ Samarkand Group plc: FY21 Preliminary Unaudited -5-

Proceeds from borrowings                               1,833,400    1,958,729 
Repayment of borrowings                               (3,703,069)   (271,733) 
Net cash from financing activities                          13,846,994   1,453,564 
 
Net increase in cash and cash equivalents                      14,052,795   303,386 
 
Cash and cash equivalents - beginning of the year                  572,586     270,564 
 
Effects of exchange rate changes on the balance of cash held in foreign currencies 
                                           (18,514)    (1,364) 
Cash and cash equivalents - end of the year                     14,606,867   572,586 

Notes to the Consolidated Financial Statements For the year ended 31 March 2021 1. General information

Samarkand Group plc was incorporated in England and Wales on 12 January 2021 as a public company with limited liability under the Companies Act 2006.

Samarkand Group plc's registered office is Unit 13 & 14 Nelson Trading Estate, The Path, Merton, London SW19 3BL.

The Consolidated Group financial statements represents the consolidated results of Samarkand Group plc and its subsidiaries, (together referred to as the "Group"). The Parent Company financial statements present information about the Company as a separate entity and not about its Group.

These are the first consolidated financial statements of the Group following the reorganisation of the Group to facilitate the listing. The result of the application of the capital reorganisation is to present the consolidated financial statements (including comparatives) as if the Company has always owned the Group. The share capital structure of the Company as at the date of the Group reorganisation is pushed back to the first date of the comparative period (1 April 2020). A Merger Reserve is created as a separate component of equity, representing the difference between the share capital of the Company at the date of the Group reorganisation and that of the previous parent of the Group, Samarkand Holdings Limited.

The financial information set out in this announcement does not constitute the Company's statutory financial statements for the year ended 31 March 2021. Whilst the financial information included in this preliminary announcement has been prepared in accordance with International Financial Reporting Standards (IFRS) this announcement itself does not contain sufficient financial information to comply with IFRS. The Company's statutory financial statements will be finalised subsequent to this preliminary unaudited results announcement and a copy of the statutory financial statements for the year ended 31 March 2021 will be issued to shareholders prior to the Company's Annual General Meeting. The Company expects to publish its Annual Report and full financial statements for the year ended 31 March 2021 that comply with IFRS. 2. Basis of preparation and measurement

(a) Basis of preparation

The financial statements have been prepared in accordance in accordance with International Accounting Standards in conformity with the Companies Act 2006.

Unless otherwise stated, the financial statements are presented in Pounds Sterling (GBP) which is the currency of the primary economic environment in which the Group operates.

Transactions in foreign currencies are translated into GBP at the rate of exchange on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date. The resulting gain or loss is reflected in the "Consolidated Statements of Comprehensive Income" within either "Finance income" or "Finance costs".

The financial statements have been prepared under the historical cost convention except for certain financial instruments that have been measured at fair value.

The financial statements have been prepared on the going concern basis, which contemplates the continuity of normal business activity and the realisation of assets and the settlement of liabilities in the normal course of business. The directors of Samarkand Group plc have reviewed the Group's overall position and outlook and are of the opinion that the Group is sufficiently well funded to be able to operate as a going concern for at least the next twelve months from the date of approval of these financial statements

(b) Basis of consolidation

The Consolidated Group financial statements comprises the financial statements of Samarkand Group plc and its subsidiaries.

A subsidiary is defined as an entity over which Samarkand Group plc has control. Samarkand Group plc controls an entity when the Group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases.

Changes in the Group's interest in a subsidiary that do not result in a loss of control are accounted for as equity transactions. The carrying amounts of the Group's interests and the non-controlling interests are adjusted to reflect the changes in their relative interests in the subsidiary. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognised directly in equity and attributed to owners of the Company.

Intra-group transactions, balances and unrealised gains on transactions are eliminated; unrealised losses are also eliminated unless cost cannot be recovered. Where necessary, adjustments are made to the financial statements of subsidiaries to ensure consistency of accounting policies with those of the Group.

The total comprehensive income of non-wholly owned subsidiaries is attributed to owners of the parent and to the non-controlling interests in proportion to their relative ownership interests.

(c) New standards and interpretations

New standards impacting the Group that have been adopted in the annual financial statements for the year ended 31 March 2021 are: - Definition of a Business (Amendments to IFRS 3); - Interest Rate Benchmark Reform - IBOR 'phase 2' (Amendments to IFRS 9, IAS 39 and IFRS 7); and - COVID-19-Related Rent Concessions (Amendments to IFRS 16).

Management anticipates that these new standards, interpretations and amendments will be adopted in the financial statements as and when they are applicable and adoption of these new standards, interpretations and amendments, will be reviewed for their impact on the financial statements prior to their initial application. 3. Segmental analysis

An analysis of the Group's revenue and cost of sales is as follows:

31 March 2021  31 March 2020 
                    GBP        GBP 
Revenue by business unit: 
Brand ownership             3,518,615    2,119,654 
NOMAD technology            6,360,740    1,527,094 
Distribution              4,832,644    3,191,211 
Exceptional revenue           5,780,000    - 
Other                  108,542     6,141 
Total revenue              20,600,541   6,844,100 
 
Revenue by geographical destination: 
UK                   8,960,128    2,910,994 
China                  11,131,560   3,497,842 
Rest of the world            508,853     435,264 
Total revenue              20,600,541   6,844,100 
 
Cost of sale by business unit: 
Brand ownership             1,126,480    998,333 
NOMAD technology            2,001,204    536,369 
Distribution              2,496,299    2,006,172 
Exceptional               3,091,046    - 
Other                  55,858     21,674 
Total costs of sale           8,770,887    3,562,548 

Exceptional revenues:

With teams in both the UK and China, the Group was ideally positioned to source and supply products necessary for the coronavirus response. As a result, a GBP5.8m government contract from the Department of Health and Social Care (DHSC) (the "Exceptional Revenue") was awarded to the Company in April 2020 for the supply of personal protective equipment. This contract was successfully fulfilled on time and within budget.

Segment assets:

The non-current assets of the Group are not measured or reported internally on a segmental basis as they are not considered to be attributable to any specific business segment. 4. Expenses by nature

An analysis of the Group's expenses by nature is as follows:

31 March 2021  31 March 2020 
                 GBP        GBP 
Administrative expenses: 
Property costs          227,910     253,729 
Staff costs           2,982,338    1,749,679 
Professional fees        382,068     201,240 
Other              426,886     386,581 
Share based payment       26,914     - 
IPO costs            460,174     - 
Total administrative expenses  4,506,290    2,591,229 5. Earnings per share 
                       31 March 2021  31 March 2020 
Basic and diluted earnings/(loss) per share  0.78 pence   (3.93) pence 
Basic and diluted number of shares in issue  51,618,966   35,340,000 

(MORE TO FOLLOW) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

DJ Samarkand Group plc: FY21 Preliminary Unaudited -6-

Basic earnings per share is calculated by dividing the profit/(loss) after tax attributable to the equity holders of Samarkand Group plc by number of shares in issue after the allotment of ordinary shares on 22 March 2021. The same number of shares is used for the corresponding period in order to provide a meaningful comparison. 6. Taxation

The components of the provision for taxation on income included in the "Statement of Profit or Loss and Other Comprehensive Income" for the periods presented are summarised below:

31 March 2021  31 March 2020 
                 GBP        GBP 
Current tax 
UK corporate income tax credit  (168,776)    (35,509) 
Deferred tax 
UK deferred income tax credit   (8,738)     (8,738) 
Total income tax credit      (177,514)    (44,247) 

The differences between the statutory income tax rate and the effective tax rates are summarised as follows:

31 March 2021  31 March 2020 
                              GBP        GBP 
 
Profit/(loss) before tax for the year           229,543     (1,431,806) 
 
 
Expected tax at statutory UK corporation tax rate of 19%  43,613 
                                      (272,043) 
Increase/(decrease) in tax resulting from: 
Effect of different tax rates in foreign jurisdictions   76,829     58,567 
Research and development tax credits            (168,776)    (35,509) 
Tax losses utilised                    (131,381)    150,660 
Capital allowances less depreciation            (6,151)     (1,159) 
Over provision in previous periods             (10,822)    - 
Deferred tax credit                    (8,738)     (8,738) 
Non-deductible expenditure                 27,912     63,975 
                              (177,514)    (44,247) 

The Group had a deferred tax liability of GBP67,576 as at 31 March 2021 (31 March 2020: GBP76,314. The deferred tax liabilities relate to taxable temporary differences.

As at 31 March, the Group had GBP1,492,553 of tax losses available to be carried forward against future profits (31 March 2020: GBP2,184,034). 7. Intangible assets - Group

Development costs  Trademarks  Brands  Goodwill  Total 
                    GBP          GBP      GBP     GBP     GBP 
Cost 
At 1 April 2019             193,614       13,999    459,916  57,807   725,336 
Additions                439,760       27,328    -     -     467,088 
At 31 March 2020            633,374       41,327    459,916  57,807   1,192,424 
 
 
Additions                557,181       29,045    -     -     586,226 
 
Additions through business combinations 
                    -          -      10,235  -     10,235 
At 31 March 2021            1,190,555      70,372    470,151  57,807   1,788,885 
 
Amortisation 
At 1 April 2019             -          1,077    57,490  -     58,567 
Charge for the year           -          4,491    45,993  -     50,484 
At 31 March 2020            -          5,568    103,483  -     109,051 
Charge for the year           163,067       7,775    46,011  -     216,853 
At 31 March 2021            163,067       13,343    149,494       325,904 
 
Net book value 
At 31 March 2021            1,027,488      57,029    320,657  57,807   1,462,981 
At 31 March 2020            633,374       35,759    356,433  57,807   1,083,373 8. Inventories 
                         31 March 2021  31 March 2020 
                         GBP        GBP 
Finished goods                  1,908,560    1,315,193 
Provision for obsolescence            (51,321)    (20,000) 
Total inventories                 1,857,239    1,295,193 
 
Cost of inventory recognised in profit and loss  8,770,887    3,562,548 9. Share capital and merger relief reserve 

The following table summarises the share capital of Samarkand Group plc for the periods presented:

Number of shares  Share capital 
                                  No.        GBP 
 
Issued share capital in Samarkand Holdings Ltd at 31 March 2020 
                                  1,767       1,767 
Sub-division of shares                     (a) 174,933      - 
At 31 March 2020                          176,700      1,767 
 
Exchanged for shares in Samarkand Group plc           (b) 35,340,000     353,400 
Share issued on incorporation                    1         - 
Shares issued on 22 March 2021                   16,278,965     162,790 
At 31 March 2021                          51,618,966     516,190 a. By way of an ordinary resolution passed on 24 September 2020, Samarkand Holdings Limited resolved to sub-divide 

each of its ordinary shares of GBP1.00 each in issue into 100 ordinary shares of GBP0.01 each. Accordingly, the number

of shares in issue increased from 1,767 to 176,700. b. On 16 February 2021, Samarkand Group plc issued 35,340,000 ordinary shares of GBP0,01 each in exchange for the entire

share capital of Samarkand Holdings Limited on the basis of 1 ordinary share in Samarkand Holdings Limited for 200

shares in Samarkand Group plc.

Shareholders are entitled to receive dividends as declared from time to time and are entitled to one vote per ordinary share at meetings of Samarkand Group plc.

Merger relief reserve

At 31 March 2021, the merger relief reserve arises from the issue of shares by Samarkand Group plc in exchange for shares in Samarkand Holdings Limited. At 31 March 2020, the merger relief reserve arises from the issue of shares by Samarkand Holdings Limited in exchange for shares in Samarkand Global Limited. In both cases, merger relief has been applied to those shares issued on a share for share basis. 10. Notes to the statements of cash flows

Net debt reconciliation:

Opening balances Cash flows Foreign exchange movements Closing balances 
                GBP        GBP      GBP             GBP 
Year ended 31 March 2021 
Cash & cash equivalents    572,586     14,052,795 (18,514)          14,606,867 
Right of use lease liabilities (1,216,486)   243,492   -             (972,994) 
Borrowings           (4,746,478)   2,663,940  -             (2,082,538) 
Directors' loans        (499,511)    499,511   -             - 
Totals             (5,889,889)   17,459,738 (18,514)          11,551,335 
 
Year ended 31 March 2020 
Cash & cash equivalents    270,564     303,386   (1,364)          572,586 
Right of use lease liabilities (1,375,998)   159,512   -             (1,216,486) 
Borrowings           (2,870,198)   (1,876,280) -             (4,746,478) 
Directors' loans        (499,511)    -      -             (499,511) 
Totals             (4,475,143)   (1,413,382) (1,364)          (5,889,889) 11. Material subsequent events 

On 4 May 2021, the Group announced that it had acquired the entire share capital of London based Zita West Products Limited (ZWPL), www.zitawest.com, and 51% of Babawest (BW), www.babawest.co.uk, for a total consideration of GBP2.4m. For the 6 month period ending 31 March 2021, ZWPL generated unaudited revenue of GBP635,901, a 60% increase on the same period in the previous year.

On 10 May 2021, the Group announced a placing of 2,737,840 new ordinary shares at a price of 115 pence raising GBP3,148,516 from United Win Asia Limited, a subsidiary of S.F. Holding Co., Ltd., as part of a strategic investment to further develop the Group's international expansion and technology. -----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00BLH1QT30 
Category Code: FR 
TIDM:      SMK 
Sequence No.:  118693 
EQS News ID:  1222495 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1222495&application_name=news 
 

(END) Dow Jones Newswires

July 29, 2021 02:00 ET (06:00 GMT)

© 2021 Dow Jones News
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.